These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19944736)

  • 1. A novel animal model to evaluate the ability of a drug delivery system to promote the passage through the BBB.
    Iannone M; Cosco D; Cilurzo F; Celia C; Paolino D; Mollace V; Rotiroti D; Fresta M
    Neurosci Lett; 2010 Jan; 469(1):93-6. PubMed ID: 19944736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles.
    Wilson B; Samanta MK; Santhi K; Kumar KP; Paramakrishnan N; Suresh B
    Eur J Pharm Biopharm; 2008 Sep; 70(1):75-84. PubMed ID: 18472255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nose-to-brain delivery of tacrine.
    Jogani VV; Shah PJ; Mishra P; Mishra AK; Misra AR
    J Pharm Pharmacol; 2007 Sep; 59(9):1199-205. PubMed ID: 17883890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic administration of N omega-nitro-L-arginine methyl ester and indomethacin reduces the elevation of brain PGE2 content and prevents seizures and hippocampal damage evoked by LiCl and tacrine in rat.
    Paoletti AM; Piccirilli S; Costa N; Rotiroti D; Bagetta G; Nisticò G
    Exp Neurol; 1998 Feb; 149(2):349-55. PubMed ID: 9500967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel tacrine-grafted Ugi adducts as multipotent anti-Alzheimer drugs: a synthetic renewal in tacrine-ferulic acid hybrids.
    Benchekroun M; Bartolini M; Egea J; Romero A; Soriano E; Pudlo M; Luzet V; Andrisano V; Jimeno ML; López MG; Wehle S; Gharbi T; Refouvelet B; de Andrés L; Herrera-Arozamena C; Monti B; Bolognesi ML; Rodríguez-Franco MI; Decker M; Marco-Contelles J; Ismaili L
    ChemMedChem; 2015 Mar; 10(3):523-39. PubMed ID: 25537267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrine and its 7-methoxy derivate; time-change concentration in plasma and brain tissue and basic toxicological profile in rats.
    Zdarova Karasova J; Soukup O; Korabecny J; Hroch M; Krejciova M; Hrabinova M; Misik J; Novotny L; Hepnarova V; Kuca K
    Drug Chem Toxicol; 2021 Mar; 44(2):207-214. PubMed ID: 31257938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier.
    Wohlfart S; Khalansky AS; Gelperina S; Begley D; Kreuter J
    J Control Release; 2011 Aug; 154(1):103-7. PubMed ID: 21616104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles.
    Kurakhmaeva KB; Djindjikhashvili IA; Petrov VE; Balabanyan VU; Voronina TA; Trofimov SS; Kreuter J; Gelperina S; Begley D; Alyautdin RN
    J Drug Target; 2009 Sep; 17(8):564-74. PubMed ID: 19694610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthesis of prodrugs of tacrine hydrochloride and evaluation of the stability and biodistribution in mice].
    Jiang Y; Zhang Y; Zhang ZR
    Yao Xue Xue Bao; 2003 Dec; 38(12):962-5. PubMed ID: 15040096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles.
    Garcia-Garcia E; Gil S; Andrieux K; Desmaële D; Nicolas V; Taran F; Georgin D; Andreux JP; Roux F; Couvreur P
    Cell Mol Life Sci; 2005 Jun; 62(12):1400-8. PubMed ID: 15905957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant delivery of tacrine into the brain using magnetic chitosan microparticles for treating Alzheimer's disease.
    Wilson B; Samanta MK; Santhi K; Sampath Kumar KP; Ramasamy M; Suresh B
    J Neurosci Methods; 2009 Mar; 177(2):427-33. PubMed ID: 19041670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saturable distribution of tacrine into the striatal extracellular fluid of the rat: evidence of involvement of multiple organic cation transporters in the transport.
    Sung JH; Yu KH; Park JS; Tsuruo T; Kim DD; Shim CK; Chung SJ
    Drug Metab Dispos; 2005 Mar; 33(3):440-8. PubMed ID: 15547049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease.
    Wilson B; Samanta MK; Santhi K; Kumar KP; Paramakrishnan N; Suresh B
    Brain Res; 2008 Mar; 1200():159-68. PubMed ID: 18291351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance.
    Mc Carthy DJ; Malhotra M; O'Mahony AM; Cryan JF; O'Driscoll CM
    Pharm Res; 2015 Apr; 32(4):1161-85. PubMed ID: 25446769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrine-induced seizures and brain damage in LiCl-treated rats can be prevented by N omega-nitro-L-arginine methyl ester.
    Bagetta G; Iannone M; Scorsa AM; Nisticò G
    Eur J Pharmacol; 1992 Mar; 213(2):301-4. PubMed ID: 1325916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle delivery to the brain--By focused ultrasound and self-assembled nanoparticle-stabilized microbubbles.
    Åslund AKO; Berg S; Hak S; Mørch Ý; Torp SH; Sandvig A; Widerøe M; Hansen R; de Lange Davies C
    J Control Release; 2015 Dec; 220(Pt A):287-294. PubMed ID: 26518721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal mucoadhesive microemulsion of tacrine to improve brain targeting.
    Jogani VV; Shah PJ; Mishra P; Mishra AK; Misra AR
    Alzheimer Dis Assoc Disord; 2008; 22(2):116-24. PubMed ID: 18525282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood-brain barrier.
    Tosi G; Fano RA; Bondioli L; Badiali L; Benassi R; Rivasi F; Ruozi B; Forni F; Vandelli MA
    Nanomedicine (Lond); 2011 Apr; 6(3):423-36. PubMed ID: 21542682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-enabled delivery systems across the blood-brain barrier.
    Hwang SR; Kim K
    Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer's disease.
    Zhang C; Chen J; Feng C; Shao X; Liu Q; Zhang Q; Pang Z; Jiang X
    Int J Pharm; 2014 Jan; 461(1-2):192-202. PubMed ID: 24300213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.